Epilepsy Pipeline Review 2020: Therapeutic Analysis Report Featuring 140+ Companies & Drug Profiles – ResearchAndMarkets.com
October 13, 2020DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Review, H2 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering.
Epilepsy – Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Epilepsy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Epilepsy (Central Nervous System) pipeline guide also reviews the key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 10, 1, 4, 28, 29, 5, 113, 24 and 4 respectively. Similarly, the Universities portfolio in Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 2, 1, 22 and 3 molecules, respectively.
Epilepsy (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:
Introduction
- Epilepsy – Overview
- Epilepsy – Therapeutics Development
Epilepsy – Therapeutics Assessment
Epilepsy – Companies Involved in Therapeutics Development
Epilepsy – Drug Profiles
Epilepsy – Dormant Projects
- Epilepsy – Discontinued Products
- Epilepsy – Product Development Milestones
Appendix
Companies Mentioned
- Aadi Bioscience Inc
- Advanced Neural Dynamics Inc
- Advicenne SA
- Aequus Pharmaceuticals Inc
- AfaSci Inc
- Affectis Pharmaceuticals AG
- AgoneX Biopharmaceuticals Inc
- AMO Pharma Ltd
- Anavex Life Sciences Corp
- Aphios Corp
- Aquestive Therapeutics Inc
- Arena Pharmaceuticals Inc
- Aucta Pharmaceuticals LLC
- Auris Medical Holding Ltd
- Avicanna Inc
- Axium Pharmaceuticals Inc
- B&A Therapeutics
- Baergic Bio Inc
- BCWorld Pharm Co Ltd
- Benuvia Therapeutics Inc
- Bial – Portela & Ca SA
- Bio-Pharm Solutions Co Ltd
- Bioasis Technologies Inc
- Bioinnotis
- Biovista Inc
- Bloom Science Inc
- Bristol-Myers Squibb Co
- Cann Pharmaceutical Australia Ltd
- Cavion LLC
- Celavie Biosciences LLC
- Cellix Bio Pvt Ltd
- Cerebral Therapeutics Inc
- Cerecin Inc
- Cerevel Therapeutics LLC
- Coda Biotherapeutics Inc
- CombiGene AB
- Crossject SA
- CuroNZ Ltd
- CURx Pharmaceuticals Inc
- Cypralis Ltd
- Eisai Co Ltd
- Encoded Therapeutics Inc
- Epalex Corp
- EpyGenix Therapeutics Inc
- ES Therapeutics LLC
- Eton Pharmaceuticals Inc
- Ferring Pharmaceuticals Inc
- GABA Therapeutics Inc
- GAOMA Therapeutics
- Genentech USA Inc
- Generoath Co Ltd
- Genus Lifesciences Inc
- Guangzhou Cellprotek Pharmaceutical Co Ltd
- GW Pharmaceuticals Plc
- Harbin Pharmaceutical Group Co Ltd
- Harvest One Cannabis Inc
- ImmunoChem Therapeutics LLC
- Ionis Pharmaceuticals Inc
- Iproteos SL
- JC Pharma Inc
- Jiangsu Simcere Pharmaceutical Co Ltd
- Johnson & Johnson
- Ketogen Inc
- Klaria Pharma Holding AB
- Knopp Biosciences LLC
- LATITUDE Pharmaceuticals Inc
- Lead Discovery Center GmbH
- LifeSplice Pharma LLC
- Luminus Biosciences Inc
- Marinus Pharmaceuticals Inc
- Medicure Inc
- Medlab Clinical Ltd
- Mercaptor Discoveries Inc
- MGC Pharmaceuticals Ltd
- Mucodel Pharma LLC
- MyX Therapeutics Inc
- NeuCyte Inc
- NeurAegis Inc
- Neurelis Inc
- NeuroAdjuvants Inc
- Neurocrine Biosciences Inc
- NeuroCycle Therapeutics Inc
- Neuroene Therapeutics LLC
- Neurolink, Inc
- Neuron Biopharma SA
- Neurona Therapeutics Inc
- New Amsterdam Sciences Inc
- Nissan Chemical Corp
- NoNO Inc
- NuBioPharma LLC
- OB Pharmaceuticals
- OPKO Health Inc
- Otsuka Holdings Co Ltd
- Ovid Therapeutics Inc
- OWP Pharmaceuticals Inc
- Panaxia Pharmaceutical Industries Ltd
- Pfizer Inc
- PharmatrophiX Inc
- Praxis Precision Medicines Inc
- Promius Pharma LLC
- Proniras Corp
- Protheragen Inc
- Proveca Ltd
- PTC Therapeutics Inc
- Q-State Biosciences Inc
- reMYND NV
- RespireRx Pharmaceuticals Inc
- RogCon Inc
- Sage Therapeutics Inc
- Saniona AB
- Scientus Pharma Inc
- Sedor Pharmaceuticals LLC
- Serina Therapeutics Inc
- Shanghai Zhimeng Biopharma Inc
- SK Biopharmaceuticals Co Ltd
- Stoke Therapeutics Inc
- StrideBio Inc
- Suda Pharmaceuticals Ltd
- Sumitomo Dainippon Pharma Co Ltd
- Sun Pharma Advanced Research Company Ltd
- Supernus Pharmaceuticals Inc
- Sustained Nano Systems LLC
- Taho Pharmaceuticals Ltd
- Takeda Pharmaceutical Co Ltd
- Taysha Gene Therapies
- Techfields Pharma Co Ltd
- The Cell Factory BVBA
- Therapix Biosciences Ltd
- Trevena Inc
- UCB SA
- Ultragenyx Pharmaceutical Inc
- Valerion Therapeutics LLC
- VistaGen Therapeutics Inc
- Vitality Biopharma Inc
- WhanIn Pharmaceutical Co Ltd
- Xenon Pharmaceuticals Inc
- XERIS Pharmaceuticals Inc
- Xi’an Libang Pharmaceuticals Co Ltd
- XPhyto Therapeutic Corp
- XW Laboratories Inc
- Zhejiang Conba Pharmaceutical Co Ltd
- Zogenix Inc
- Zynerba Pharmaceuticals Inc
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/3oqs8q
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Epilepsy Pipeline Review 2020: Therapeutic Analysis Report Featuring 140+ Companies & Drug Profiles – ResearchAndMarkets.com
October 13, 2020DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Review, H2 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering.
Epilepsy – Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Epilepsy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Epilepsy (Central Nervous System) pipeline guide also reviews the key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 10, 1, 4, 28, 29, 5, 113, 24 and 4 respectively. Similarly, the Universities portfolio in Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 2, 1, 22 and 3 molecules, respectively.
Epilepsy (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:
Introduction
- Epilepsy – Overview
- Epilepsy – Therapeutics Development
Epilepsy – Therapeutics Assessment
Epilepsy – Companies Involved in Therapeutics Development
Epilepsy – Drug Profiles
Epilepsy – Dormant Projects
- Epilepsy – Discontinued Products
- Epilepsy – Product Development Milestones
Appendix
Companies Mentioned
- Aadi Bioscience Inc
- Advanced Neural Dynamics Inc
- Advicenne SA
- Aequus Pharmaceuticals Inc
- AfaSci Inc
- Affectis Pharmaceuticals AG
- AgoneX Biopharmaceuticals Inc
- AMO Pharma Ltd
- Anavex Life Sciences Corp
- Aphios Corp
- Aquestive Therapeutics Inc
- Arena Pharmaceuticals Inc
- Aucta Pharmaceuticals LLC
- Auris Medical Holding Ltd
- Avicanna Inc
- Axium Pharmaceuticals Inc
- B&A Therapeutics
- Baergic Bio Inc
- BCWorld Pharm Co Ltd
- Benuvia Therapeutics Inc
- Bial – Portela & Ca SA
- Bio-Pharm Solutions Co Ltd
- Bioasis Technologies Inc
- Bioinnotis
- Biovista Inc
- Bloom Science Inc
- Bristol-Myers Squibb Co
- Cann Pharmaceutical Australia Ltd
- Cavion LLC
- Celavie Biosciences LLC
- Cellix Bio Pvt Ltd
- Cerebral Therapeutics Inc
- Cerecin Inc
- Cerevel Therapeutics LLC
- Coda Biotherapeutics Inc
- CombiGene AB
- Crossject SA
- CuroNZ Ltd
- CURx Pharmaceuticals Inc
- Cypralis Ltd
- Eisai Co Ltd
- Encoded Therapeutics Inc
- Epalex Corp
- EpyGenix Therapeutics Inc
- ES Therapeutics LLC
- Eton Pharmaceuticals Inc
- Ferring Pharmaceuticals Inc
- GABA Therapeutics Inc
- GAOMA Therapeutics
- Genentech USA Inc
- Generoath Co Ltd
- Genus Lifesciences Inc
- Guangzhou Cellprotek Pharmaceutical Co Ltd
- GW Pharmaceuticals Plc
- Harbin Pharmaceutical Group Co Ltd
- Harvest One Cannabis Inc
- ImmunoChem Therapeutics LLC
- Ionis Pharmaceuticals Inc
- Iproteos SL
- JC Pharma Inc
- Jiangsu Simcere Pharmaceutical Co Ltd
- Johnson & Johnson
- Ketogen Inc
- Klaria Pharma Holding AB
- Knopp Biosciences LLC
- LATITUDE Pharmaceuticals Inc
- Lead Discovery Center GmbH
- LifeSplice Pharma LLC
- Luminus Biosciences Inc
- Marinus Pharmaceuticals Inc
- Medicure Inc
- Medlab Clinical Ltd
- Mercaptor Discoveries Inc
- MGC Pharmaceuticals Ltd
- Mucodel Pharma LLC
- MyX Therapeutics Inc
- NeuCyte Inc
- NeurAegis Inc
- Neurelis Inc
- NeuroAdjuvants Inc
- Neurocrine Biosciences Inc
- NeuroCycle Therapeutics Inc
- Neuroene Therapeutics LLC
- Neurolink, Inc
- Neuron Biopharma SA
- Neurona Therapeutics Inc
- New Amsterdam Sciences Inc
- Nissan Chemical Corp
- NoNO Inc
- NuBioPharma LLC
- OB Pharmaceuticals
- OPKO Health Inc
- Otsuka Holdings Co Ltd
- Ovid Therapeutics Inc
- OWP Pharmaceuticals Inc
- Panaxia Pharmaceutical Industries Ltd
- Pfizer Inc
- PharmatrophiX Inc
- Praxis Precision Medicines Inc
- Promius Pharma LLC
- Proniras Corp
- Protheragen Inc
- Proveca Ltd
- PTC Therapeutics Inc
- Q-State Biosciences Inc
- reMYND NV
- RespireRx Pharmaceuticals Inc
- RogCon Inc
- Sage Therapeutics Inc
- Saniona AB
- Scientus Pharma Inc
- Sedor Pharmaceuticals LLC
- Serina Therapeutics Inc
- Shanghai Zhimeng Biopharma Inc
- SK Biopharmaceuticals Co Ltd
- Stoke Therapeutics Inc
- StrideBio Inc
- Suda Pharmaceuticals Ltd
- Sumitomo Dainippon Pharma Co Ltd
- Sun Pharma Advanced Research Company Ltd
- Supernus Pharmaceuticals Inc
- Sustained Nano Systems LLC
- Taho Pharmaceuticals Ltd
- Takeda Pharmaceutical Co Ltd
- Taysha Gene Therapies
- Techfields Pharma Co Ltd
- The Cell Factory BVBA
- Therapix Biosciences Ltd
- Trevena Inc
- UCB SA
- Ultragenyx Pharmaceutical Inc
- Valerion Therapeutics LLC
- VistaGen Therapeutics Inc
- Vitality Biopharma Inc
- WhanIn Pharmaceutical Co Ltd
- Xenon Pharmaceuticals Inc
- XERIS Pharmaceuticals Inc
- Xi’an Libang Pharmaceuticals Co Ltd
- XPhyto Therapeutic Corp
- XW Laboratories Inc
- Zhejiang Conba Pharmaceutical Co Ltd
- Zogenix Inc
- Zynerba Pharmaceuticals Inc
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/3oqs8q
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Epilepsy Pipeline Review 2020: Therapeutic Analysis Report Featuring 140+ Companies & Drug Profiles – ResearchAndMarkets.com
October 13, 2020DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Review, H2 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering.
Epilepsy – Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Epilepsy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Epilepsy (Central Nervous System) pipeline guide also reviews the key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 10, 1, 4, 28, 29, 5, 113, 24 and 4 respectively. Similarly, the Universities portfolio in Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 2, 1, 22 and 3 molecules, respectively.
Epilepsy (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:
Introduction
- Epilepsy – Overview
- Epilepsy – Therapeutics Development
Epilepsy – Therapeutics Assessment
Epilepsy – Companies Involved in Therapeutics Development
Epilepsy – Drug Profiles
Epilepsy – Dormant Projects
- Epilepsy – Discontinued Products
- Epilepsy – Product Development Milestones
Appendix
Companies Mentioned
- Aadi Bioscience Inc
- Advanced Neural Dynamics Inc
- Advicenne SA
- Aequus Pharmaceuticals Inc
- AfaSci Inc
- Affectis Pharmaceuticals AG
- AgoneX Biopharmaceuticals Inc
- AMO Pharma Ltd
- Anavex Life Sciences Corp
- Aphios Corp
- Aquestive Therapeutics Inc
- Arena Pharmaceuticals Inc
- Aucta Pharmaceuticals LLC
- Auris Medical Holding Ltd
- Avicanna Inc
- Axium Pharmaceuticals Inc
- B&A Therapeutics
- Baergic Bio Inc
- BCWorld Pharm Co Ltd
- Benuvia Therapeutics Inc
- Bial – Portela & Ca SA
- Bio-Pharm Solutions Co Ltd
- Bioasis Technologies Inc
- Bioinnotis
- Biovista Inc
- Bloom Science Inc
- Bristol-Myers Squibb Co
- Cann Pharmaceutical Australia Ltd
- Cavion LLC
- Celavie Biosciences LLC
- Cellix Bio Pvt Ltd
- Cerebral Therapeutics Inc
- Cerecin Inc
- Cerevel Therapeutics LLC
- Coda Biotherapeutics Inc
- CombiGene AB
- Crossject SA
- CuroNZ Ltd
- CURx Pharmaceuticals Inc
- Cypralis Ltd
- Eisai Co Ltd
- Encoded Therapeutics Inc
- Epalex Corp
- EpyGenix Therapeutics Inc
- ES Therapeutics LLC
- Eton Pharmaceuticals Inc
- Ferring Pharmaceuticals Inc
- GABA Therapeutics Inc
- GAOMA Therapeutics
- Genentech USA Inc
- Generoath Co Ltd
- Genus Lifesciences Inc
- Guangzhou Cellprotek Pharmaceutical Co Ltd
- GW Pharmaceuticals Plc
- Harbin Pharmaceutical Group Co Ltd
- Harvest One Cannabis Inc
- ImmunoChem Therapeutics LLC
- Ionis Pharmaceuticals Inc
- Iproteos SL
- JC Pharma Inc
- Jiangsu Simcere Pharmaceutical Co Ltd
- Johnson & Johnson
- Ketogen Inc
- Klaria Pharma Holding AB
- Knopp Biosciences LLC
- LATITUDE Pharmaceuticals Inc
- Lead Discovery Center GmbH
- LifeSplice Pharma LLC
- Luminus Biosciences Inc
- Marinus Pharmaceuticals Inc
- Medicure Inc
- Medlab Clinical Ltd
- Mercaptor Discoveries Inc
- MGC Pharmaceuticals Ltd
- Mucodel Pharma LLC
- MyX Therapeutics Inc
- NeuCyte Inc
- NeurAegis Inc
- Neurelis Inc
- NeuroAdjuvants Inc
- Neurocrine Biosciences Inc
- NeuroCycle Therapeutics Inc
- Neuroene Therapeutics LLC
- Neurolink, Inc
- Neuron Biopharma SA
- Neurona Therapeutics Inc
- New Amsterdam Sciences Inc
- Nissan Chemical Corp
- NoNO Inc
- NuBioPharma LLC
- OB Pharmaceuticals
- OPKO Health Inc
- Otsuka Holdings Co Ltd
- Ovid Therapeutics Inc
- OWP Pharmaceuticals Inc
- Panaxia Pharmaceutical Industries Ltd
- Pfizer Inc
- PharmatrophiX Inc
- Praxis Precision Medicines Inc
- Promius Pharma LLC
- Proniras Corp
- Protheragen Inc
- Proveca Ltd
- PTC Therapeutics Inc
- Q-State Biosciences Inc
- reMYND NV
- RespireRx Pharmaceuticals Inc
- RogCon Inc
- Sage Therapeutics Inc
- Saniona AB
- Scientus Pharma Inc
- Sedor Pharmaceuticals LLC
- Serina Therapeutics Inc
- Shanghai Zhimeng Biopharma Inc
- SK Biopharmaceuticals Co Ltd
- Stoke Therapeutics Inc
- StrideBio Inc
- Suda Pharmaceuticals Ltd
- Sumitomo Dainippon Pharma Co Ltd
- Sun Pharma Advanced Research Company Ltd
- Supernus Pharmaceuticals Inc
- Sustained Nano Systems LLC
- Taho Pharmaceuticals Ltd
- Takeda Pharmaceutical Co Ltd
- Taysha Gene Therapies
- Techfields Pharma Co Ltd
- The Cell Factory BVBA
- Therapix Biosciences Ltd
- Trevena Inc
- UCB SA
- Ultragenyx Pharmaceutical Inc
- Valerion Therapeutics LLC
- VistaGen Therapeutics Inc
- Vitality Biopharma Inc
- WhanIn Pharmaceutical Co Ltd
- Xenon Pharmaceuticals Inc
- XERIS Pharmaceuticals Inc
- Xi’an Libang Pharmaceuticals Co Ltd
- XPhyto Therapeutic Corp
- XW Laboratories Inc
- Zhejiang Conba Pharmaceutical Co Ltd
- Zogenix Inc
- Zynerba Pharmaceuticals Inc
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/3oqs8q
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Epilepsy Pipeline Review 2020: Therapeutic Analysis Report Featuring 140+ Companies & Drug Profiles – ResearchAndMarkets.com
October 13, 2020DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Review, H2 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering.
Epilepsy – Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Epilepsy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Epilepsy (Central Nervous System) pipeline guide also reviews the key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 10, 1, 4, 28, 29, 5, 113, 24 and 4 respectively. Similarly, the Universities portfolio in Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 2, 1, 22 and 3 molecules, respectively.
Epilepsy (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:
Introduction
- Epilepsy – Overview
- Epilepsy – Therapeutics Development
Epilepsy – Therapeutics Assessment
Epilepsy – Companies Involved in Therapeutics Development
Epilepsy – Drug Profiles
Epilepsy – Dormant Projects
- Epilepsy – Discontinued Products
- Epilepsy – Product Development Milestones
Appendix
Companies Mentioned
- Aadi Bioscience Inc
- Advanced Neural Dynamics Inc
- Advicenne SA
- Aequus Pharmaceuticals Inc
- AfaSci Inc
- Affectis Pharmaceuticals AG
- AgoneX Biopharmaceuticals Inc
- AMO Pharma Ltd
- Anavex Life Sciences Corp
- Aphios Corp
- Aquestive Therapeutics Inc
- Arena Pharmaceuticals Inc
- Aucta Pharmaceuticals LLC
- Auris Medical Holding Ltd
- Avicanna Inc
- Axium Pharmaceuticals Inc
- B&A Therapeutics
- Baergic Bio Inc
- BCWorld Pharm Co Ltd
- Benuvia Therapeutics Inc
- Bial – Portela & Ca SA
- Bio-Pharm Solutions Co Ltd
- Bioasis Technologies Inc
- Bioinnotis
- Biovista Inc
- Bloom Science Inc
- Bristol-Myers Squibb Co
- Cann Pharmaceutical Australia Ltd
- Cavion LLC
- Celavie Biosciences LLC
- Cellix Bio Pvt Ltd
- Cerebral Therapeutics Inc
- Cerecin Inc
- Cerevel Therapeutics LLC
- Coda Biotherapeutics Inc
- CombiGene AB
- Crossject SA
- CuroNZ Ltd
- CURx Pharmaceuticals Inc
- Cypralis Ltd
- Eisai Co Ltd
- Encoded Therapeutics Inc
- Epalex Corp
- EpyGenix Therapeutics Inc
- ES Therapeutics LLC
- Eton Pharmaceuticals Inc
- Ferring Pharmaceuticals Inc
- GABA Therapeutics Inc
- GAOMA Therapeutics
- Genentech USA Inc
- Generoath Co Ltd
- Genus Lifesciences Inc
- Guangzhou Cellprotek Pharmaceutical Co Ltd
- GW Pharmaceuticals Plc
- Harbin Pharmaceutical Group Co Ltd
- Harvest One Cannabis Inc
- ImmunoChem Therapeutics LLC
- Ionis Pharmaceuticals Inc
- Iproteos SL
- JC Pharma Inc
- Jiangsu Simcere Pharmaceutical Co Ltd
- Johnson & Johnson
- Ketogen Inc
- Klaria Pharma Holding AB
- Knopp Biosciences LLC
- LATITUDE Pharmaceuticals Inc
- Lead Discovery Center GmbH
- LifeSplice Pharma LLC
- Luminus Biosciences Inc
- Marinus Pharmaceuticals Inc
- Medicure Inc
- Medlab Clinical Ltd
- Mercaptor Discoveries Inc
- MGC Pharmaceuticals Ltd
- Mucodel Pharma LLC
- MyX Therapeutics Inc
- NeuCyte Inc
- NeurAegis Inc
- Neurelis Inc
- NeuroAdjuvants Inc
- Neurocrine Biosciences Inc
- NeuroCycle Therapeutics Inc
- Neuroene Therapeutics LLC
- Neurolink, Inc
- Neuron Biopharma SA
- Neurona Therapeutics Inc
- New Amsterdam Sciences Inc
- Nissan Chemical Corp
- NoNO Inc
- NuBioPharma LLC
- OB Pharmaceuticals
- OPKO Health Inc
- Otsuka Holdings Co Ltd
- Ovid Therapeutics Inc
- OWP Pharmaceuticals Inc
- Panaxia Pharmaceutical Industries Ltd
- Pfizer Inc
- PharmatrophiX Inc
- Praxis Precision Medicines Inc
- Promius Pharma LLC
- Proniras Corp
- Protheragen Inc
- Proveca Ltd
- PTC Therapeutics Inc
- Q-State Biosciences Inc
- reMYND NV
- RespireRx Pharmaceuticals Inc
- RogCon Inc
- Sage Therapeutics Inc
- Saniona AB
- Scientus Pharma Inc
- Sedor Pharmaceuticals LLC
- Serina Therapeutics Inc
- Shanghai Zhimeng Biopharma Inc
- SK Biopharmaceuticals Co Ltd
- Stoke Therapeutics Inc
- StrideBio Inc
- Suda Pharmaceuticals Ltd
- Sumitomo Dainippon Pharma Co Ltd
- Sun Pharma Advanced Research Company Ltd
- Supernus Pharmaceuticals Inc
- Sustained Nano Systems LLC
- Taho Pharmaceuticals Ltd
- Takeda Pharmaceutical Co Ltd
- Taysha Gene Therapies
- Techfields Pharma Co Ltd
- The Cell Factory BVBA
- Therapix Biosciences Ltd
- Trevena Inc
- UCB SA
- Ultragenyx Pharmaceutical Inc
- Valerion Therapeutics LLC
- VistaGen Therapeutics Inc
- Vitality Biopharma Inc
- WhanIn Pharmaceutical Co Ltd
- Xenon Pharmaceuticals Inc
- XERIS Pharmaceuticals Inc
- Xi’an Libang Pharmaceuticals Co Ltd
- XPhyto Therapeutic Corp
- XW Laboratories Inc
- Zhejiang Conba Pharmaceutical Co Ltd
- Zogenix Inc
- Zynerba Pharmaceuticals Inc
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/3oqs8q
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Epilepsy Pipeline Review 2020: Therapeutic Analysis Report Featuring 140+ Companies & Drug Profiles – ResearchAndMarkets.com
October 13, 2020DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Review, H2 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering.
Epilepsy – Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Epilepsy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Epilepsy (Central Nervous System) pipeline guide also reviews the key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 10, 1, 4, 28, 29, 5, 113, 24 and 4 respectively. Similarly, the Universities portfolio in Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 2, 1, 22 and 3 molecules, respectively.
Epilepsy (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:
Introduction
- Epilepsy – Overview
- Epilepsy – Therapeutics Development
Epilepsy – Therapeutics Assessment
Epilepsy – Companies Involved in Therapeutics Development
Epilepsy – Drug Profiles
Epilepsy – Dormant Projects
- Epilepsy – Discontinued Products
- Epilepsy – Product Development Milestones
Appendix
Companies Mentioned
- Aadi Bioscience Inc
- Advanced Neural Dynamics Inc
- Advicenne SA
- Aequus Pharmaceuticals Inc
- AfaSci Inc
- Affectis Pharmaceuticals AG
- AgoneX Biopharmaceuticals Inc
- AMO Pharma Ltd
- Anavex Life Sciences Corp
- Aphios Corp
- Aquestive Therapeutics Inc
- Arena Pharmaceuticals Inc
- Aucta Pharmaceuticals LLC
- Auris Medical Holding Ltd
- Avicanna Inc
- Axium Pharmaceuticals Inc
- B&A Therapeutics
- Baergic Bio Inc
- BCWorld Pharm Co Ltd
- Benuvia Therapeutics Inc
- Bial – Portela & Ca SA
- Bio-Pharm Solutions Co Ltd
- Bioasis Technologies Inc
- Bioinnotis
- Biovista Inc
- Bloom Science Inc
- Bristol-Myers Squibb Co
- Cann Pharmaceutical Australia Ltd
- Cavion LLC
- Celavie Biosciences LLC
- Cellix Bio Pvt Ltd
- Cerebral Therapeutics Inc
- Cerecin Inc
- Cerevel Therapeutics LLC
- Coda Biotherapeutics Inc
- CombiGene AB
- Crossject SA
- CuroNZ Ltd
- CURx Pharmaceuticals Inc
- Cypralis Ltd
- Eisai Co Ltd
- Encoded Therapeutics Inc
- Epalex Corp
- EpyGenix Therapeutics Inc
- ES Therapeutics LLC
- Eton Pharmaceuticals Inc
- Ferring Pharmaceuticals Inc
- GABA Therapeutics Inc
- GAOMA Therapeutics
- Genentech USA Inc
- Generoath Co Ltd
- Genus Lifesciences Inc
- Guangzhou Cellprotek Pharmaceutical Co Ltd
- GW Pharmaceuticals Plc
- Harbin Pharmaceutical Group Co Ltd
- Harvest One Cannabis Inc
- ImmunoChem Therapeutics LLC
- Ionis Pharmaceuticals Inc
- Iproteos SL
- JC Pharma Inc
- Jiangsu Simcere Pharmaceutical Co Ltd
- Johnson & Johnson
- Ketogen Inc
- Klaria Pharma Holding AB
- Knopp Biosciences LLC
- LATITUDE Pharmaceuticals Inc
- Lead Discovery Center GmbH
- LifeSplice Pharma LLC
- Luminus Biosciences Inc
- Marinus Pharmaceuticals Inc
- Medicure Inc
- Medlab Clinical Ltd
- Mercaptor Discoveries Inc
- MGC Pharmaceuticals Ltd
- Mucodel Pharma LLC
- MyX Therapeutics Inc
- NeuCyte Inc
- NeurAegis Inc
- Neurelis Inc
- NeuroAdjuvants Inc
- Neurocrine Biosciences Inc
- NeuroCycle Therapeutics Inc
- Neuroene Therapeutics LLC
- Neurolink, Inc
- Neuron Biopharma SA
- Neurona Therapeutics Inc
- New Amsterdam Sciences Inc
- Nissan Chemical Corp
- NoNO Inc
- NuBioPharma LLC
- OB Pharmaceuticals
- OPKO Health Inc
- Otsuka Holdings Co Ltd
- Ovid Therapeutics Inc
- OWP Pharmaceuticals Inc
- Panaxia Pharmaceutical Industries Ltd
- Pfizer Inc
- PharmatrophiX Inc
- Praxis Precision Medicines Inc
- Promius Pharma LLC
- Proniras Corp
- Protheragen Inc
- Proveca Ltd
- PTC Therapeutics Inc
- Q-State Biosciences Inc
- reMYND NV
- RespireRx Pharmaceuticals Inc
- RogCon Inc
- Sage Therapeutics Inc
- Saniona AB
- Scientus Pharma Inc
- Sedor Pharmaceuticals LLC
- Serina Therapeutics Inc
- Shanghai Zhimeng Biopharma Inc
- SK Biopharmaceuticals Co Ltd
- Stoke Therapeutics Inc
- StrideBio Inc
- Suda Pharmaceuticals Ltd
- Sumitomo Dainippon Pharma Co Ltd
- Sun Pharma Advanced Research Company Ltd
- Supernus Pharmaceuticals Inc
- Sustained Nano Systems LLC
- Taho Pharmaceuticals Ltd
- Takeda Pharmaceutical Co Ltd
- Taysha Gene Therapies
- Techfields Pharma Co Ltd
- The Cell Factory BVBA
- Therapix Biosciences Ltd
- Trevena Inc
- UCB SA
- Ultragenyx Pharmaceutical Inc
- Valerion Therapeutics LLC
- VistaGen Therapeutics Inc
- Vitality Biopharma Inc
- WhanIn Pharmaceutical Co Ltd
- Xenon Pharmaceuticals Inc
- XERIS Pharmaceuticals Inc
- Xi’an Libang Pharmaceuticals Co Ltd
- XPhyto Therapeutic Corp
- XW Laboratories Inc
- Zhejiang Conba Pharmaceutical Co Ltd
- Zogenix Inc
- Zynerba Pharmaceuticals Inc
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/3oqs8q
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Epilepsy Pipeline Review 2020: Therapeutic Analysis Report Featuring 140+ Companies & Drug Profiles – ResearchAndMarkets.com
October 13, 2020DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Review, H2 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering.
Epilepsy – Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Epilepsy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Epilepsy (Central Nervous System) pipeline guide also reviews the key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 10, 1, 4, 28, 29, 5, 113, 24 and 4 respectively. Similarly, the Universities portfolio in Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 2, 1, 22 and 3 molecules, respectively.
Epilepsy (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:
Introduction
- Epilepsy – Overview
- Epilepsy – Therapeutics Development
Epilepsy – Therapeutics Assessment
Epilepsy – Companies Involved in Therapeutics Development
Epilepsy – Drug Profiles
Epilepsy – Dormant Projects
- Epilepsy – Discontinued Products
- Epilepsy – Product Development Milestones
Appendix
Companies Mentioned
- Aadi Bioscience Inc
- Advanced Neural Dynamics Inc
- Advicenne SA
- Aequus Pharmaceuticals Inc
- AfaSci Inc
- Affectis Pharmaceuticals AG
- AgoneX Biopharmaceuticals Inc
- AMO Pharma Ltd
- Anavex Life Sciences Corp
- Aphios Corp
- Aquestive Therapeutics Inc
- Arena Pharmaceuticals Inc
- Aucta Pharmaceuticals LLC
- Auris Medical Holding Ltd
- Avicanna Inc
- Axium Pharmaceuticals Inc
- B&A Therapeutics
- Baergic Bio Inc
- BCWorld Pharm Co Ltd
- Benuvia Therapeutics Inc
- Bial – Portela & Ca SA
- Bio-Pharm Solutions Co Ltd
- Bioasis Technologies Inc
- Bioinnotis
- Biovista Inc
- Bloom Science Inc
- Bristol-Myers Squibb Co
- Cann Pharmaceutical Australia Ltd
- Cavion LLC
- Celavie Biosciences LLC
- Cellix Bio Pvt Ltd
- Cerebral Therapeutics Inc
- Cerecin Inc
- Cerevel Therapeutics LLC
- Coda Biotherapeutics Inc
- CombiGene AB
- Crossject SA
- CuroNZ Ltd
- CURx Pharmaceuticals Inc
- Cypralis Ltd
- Eisai Co Ltd
- Encoded Therapeutics Inc
- Epalex Corp
- EpyGenix Therapeutics Inc
- ES Therapeutics LLC
- Eton Pharmaceuticals Inc
- Ferring Pharmaceuticals Inc
- GABA Therapeutics Inc
- GAOMA Therapeutics
- Genentech USA Inc
- Generoath Co Ltd
- Genus Lifesciences Inc
- Guangzhou Cellprotek Pharmaceutical Co Ltd
- GW Pharmaceuticals Plc
- Harbin Pharmaceutical Group Co Ltd
- Harvest One Cannabis Inc
- ImmunoChem Therapeutics LLC
- Ionis Pharmaceuticals Inc
- Iproteos SL
- JC Pharma Inc
- Jiangsu Simcere Pharmaceutical Co Ltd
- Johnson & Johnson
- Ketogen Inc
- Klaria Pharma Holding AB
- Knopp Biosciences LLC
- LATITUDE Pharmaceuticals Inc
- Lead Discovery Center GmbH
- LifeSplice Pharma LLC
- Luminus Biosciences Inc
- Marinus Pharmaceuticals Inc
- Medicure Inc
- Medlab Clinical Ltd
- Mercaptor Discoveries Inc
- MGC Pharmaceuticals Ltd
- Mucodel Pharma LLC
- MyX Therapeutics Inc
- NeuCyte Inc
- NeurAegis Inc
- Neurelis Inc
- NeuroAdjuvants Inc
- Neurocrine Biosciences Inc
- NeuroCycle Therapeutics Inc
- Neuroene Therapeutics LLC
- Neurolink, Inc
- Neuron Biopharma SA
- Neurona Therapeutics Inc
- New Amsterdam Sciences Inc
- Nissan Chemical Corp
- NoNO Inc
- NuBioPharma LLC
- OB Pharmaceuticals
- OPKO Health Inc
- Otsuka Holdings Co Ltd
- Ovid Therapeutics Inc
- OWP Pharmaceuticals Inc
- Panaxia Pharmaceutical Industries Ltd
- Pfizer Inc
- PharmatrophiX Inc
- Praxis Precision Medicines Inc
- Promius Pharma LLC
- Proniras Corp
- Protheragen Inc
- Proveca Ltd
- PTC Therapeutics Inc
- Q-State Biosciences Inc
- reMYND NV
- RespireRx Pharmaceuticals Inc
- RogCon Inc
- Sage Therapeutics Inc
- Saniona AB
- Scientus Pharma Inc
- Sedor Pharmaceuticals LLC
- Serina Therapeutics Inc
- Shanghai Zhimeng Biopharma Inc
- SK Biopharmaceuticals Co Ltd
- Stoke Therapeutics Inc
- StrideBio Inc
- Suda Pharmaceuticals Ltd
- Sumitomo Dainippon Pharma Co Ltd
- Sun Pharma Advanced Research Company Ltd
- Supernus Pharmaceuticals Inc
- Sustained Nano Systems LLC
- Taho Pharmaceuticals Ltd
- Takeda Pharmaceutical Co Ltd
- Taysha Gene Therapies
- Techfields Pharma Co Ltd
- The Cell Factory BVBA
- Therapix Biosciences Ltd
- Trevena Inc
- UCB SA
- Ultragenyx Pharmaceutical Inc
- Valerion Therapeutics LLC
- VistaGen Therapeutics Inc
- Vitality Biopharma Inc
- WhanIn Pharmaceutical Co Ltd
- Xenon Pharmaceuticals Inc
- XERIS Pharmaceuticals Inc
- Xi’an Libang Pharmaceuticals Co Ltd
- XPhyto Therapeutic Corp
- XW Laboratories Inc
- Zhejiang Conba Pharmaceutical Co Ltd
- Zogenix Inc
- Zynerba Pharmaceuticals Inc
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/3oqs8q
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900